Sign In

Astex Technology

Astex is a fragment-based drug discovery company pioneering high-throughput x-ray crystallography to rapidly identify new drugs. Astex’s unique approach Pyramid™ is revolutionizing the role of protein structure in discovery, accelerating the pace and providing leads for targets intractable to conventional screening. Astex uses Pyramid™ to identify novel leads for proprietary and public domain targets in both 'in house' programs and in discovery collaborations with corporate partners.

• Show past press releases
• Edit this company

Contact Information

436, Cambridge Science Park
Milton Road
Cambridge CB4 0QA
United Kingdom
+44 (0) 1223 226200
+44 (0) 1223 226201
Jeremy Carmichael
+44 (0) 1223 226200

Company Facts
Founded:Dec 1999
Founders:Dr Harren Jhoti , Prof Sir Tom Blundell FRS , Dr Chris Abell
CEO:Mr Timothy J Haines
CTO or technical lead:Dr Harren Jhoti (CSO)
CFO or finance director:
Head of Sales:Dr Nifgel Crockett (Commercial Director)
Head of Marketing:contact

Category:Biotechnology & Healthcare
Funding raised:Yes
Funding sought:No
Seeking Partnerships:Yes

Non-executive Board Members

  • Peter Fellner, Chairman, Celltech Group p
  • Prof Sir Tom Blundell FRS, Head of Biochemistry, Cambridge University
  • Mark Carthy, Venture Partner, Oxford Bioscience
  • Dr Stephen Bunting, Director, Abingworth
  • Timothy J Rink, ioscience, Aurora B
  • Patrick Van Beneden, Investment Director, GIMV

    Key Customers

  • Pharma and biotech companies

    Key Business Partners

  • Schering AG
  • AstraZeneca
  • Mitsubishi
  • Aventis
  • Fujisawa
  • Institute of Cancer Research, Uk / CRT
  • Johnson & Johnson Pharmaceutical R&D
  • Cambridge Crystallographic Data Centre

    Key Competitors

  • structure-based drug discovery companies

    Capital Raised
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    No public offerings

  • Data

    Tech investments
    From our Online Data Service
    VC-backed companies
    From our Radar

    Recent Deals

    Nov 25€24.0MInternet commerce
    Feb 21€87.0MInternet services
    Feb 21€18.0MInternet commerce
    Feb 20€4.3MSoftware development
    Feb 19€0.4MInternet commerce
    Feb 19€8.4MMedical devices
    Feb 18€25.0MBiotechnology

    For information on Europe's most extensive database on technology funding click here!


    Press Releases

    May 28
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    nethone raised over $1 million from innovation nest

    Jan 29
    yumpingo raises $10m to transform guest experiences in restaurants

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.